Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA testing utilization among commercially insured women with breast or ovarian cancer.

Breast cancer research and treatment - 1 Oct 2025

Shi Lu, Kolor Katherine, Chen Zhuo, Moonesinghe Ramal, Rodriguez Juan, Khoury Muin J, Grosse Scott D

Abstract excerpt

PURPOSE: This report examines utilization of germline BRCA genetic testing among women with breast or ovarian cancer in the context of current clinical guidelines for testing. METHODS: Linked IQVIA commercial claims and electronic medical record data were used to analyze BRCA test utilization among women aged 18-64 years with newly diagnosed breast cancer or ovarian cancer during 2016-2021, excluding 2018....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Electronic Health Records

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Insurance, Health

Share to Patient Acceptance of Health Care

Share to Practice Guidelines as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 40853608
DOI: 10.1007/s10549-025-07618-5
PMCID: PMC13389926

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA testing utilization among commercially insured women with breast or ovarian cancer.PMID 40853608Read ↗

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019Semantic proximity Read ↗

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.Semantic proximity Read ↗

Genetic testing in privately insured women with surgically treated breast cancer.Semantic proximity Read ↗

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.Semantic proximity Read ↗

Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.Semantic proximity Read ↗

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer PatientsSemantic proximity Read ↗

Disparities in Genetic Management of Breast and Ovarian Cancer Patients.Semantic proximity Read ↗

Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple SitesSemantic proximity Read ↗

Use of BRCA Mutation Test in the U.S., 2004-2014.Semantic proximity Read ↗

Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer.Semantic proximity Read ↗

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.Semantic proximity Read ↗

Availability and payer coverage of BRCA1/2 tests and gene panels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.